ACRS — Aclaris Therapeutics Inc

Price

$3.90

Change

+0.29 (+8.03%)

Open

$3.62

High

$3.98

Low

$3.62

Prev close

$3.61

Volume

3.5M

The ticker ACRS represents Aclaris Therapeutics Inc, listed on NASDAQ.

ACRS belongs to the HEALTHCARE sector and the BIOTECHNOLOGY industry.

To answer "what is ACRS worth" or "what is happening with Aclaris Therapeutics Inc", VAQO shows a live price alongside technical analysis, relevant headlines and what other investors think.

VAQO's learning model reads seven technical indicators — short and long momentum, RSI, volatility, volume ratio, moving-average cross and position in the 52-week range — and turns them into transparent opportunity and risk scores.

What ACRS is

Aclaris Therapeutics, Inc. is a clinical-stage biopharmaceutical company developing a line of novel small molecule therapeutics to address the needs of patients with immuno-inflammatory diseases. The company is headquartered in Wayne, Pennsylvania.…

Aclaris Therapeutics Inc is classified under HEALTHCARE, in the BIOTECHNOLOGY industry.

It trades on NASDAQ as a common stock.

ACRS size and valuation

At roughly $544.6M, ACRS is a small-cap.

Earnings per share are negative at -0.58, so there is no meaningful price-to-earnings multiple to quote.

Beta is 0.88: historically it has moved roughly with the market.

ACRS over the past year

Over the past year ACRS has traded between $1.74 and $6.60, and the current price sits at 44% of that range.

The 50-day average is $5.69 against a 200-day average of $4.46 — the shorter average sits above the longer one, the configuration usually read as an uptrend.

The published analyst target is $10.18, 161.0% above it. A target is an aggregate of opinions, not a measurement.

How Aclaris Therapeutics Inc (ACRS) is trading

Aclaris Therapeutics Inc (ACRS) is up 8.03% at $3.90. A move that large in a single session sits well outside the normal daily range for most stocks.

The session ranged from $3.62 to $3.98 — 9.2% of the share price — and the current price sits at 79% of that range.

It opened at 1% of the daily range and finished at 79% of it: ACRS turned around inside the session, in the buyers' favour.

The day's range extended past the previous close ($3.61) on both sides.

Volume ran near 3.5M shares, about $13.8M of stock changing hands.

Traded alongside ACRS

Names traded alongside ACRS in the same sector: A (Agilent Technologies Inc), AAPG (Ascentage Pharma Group International), AARD (Aardvark Therapeutics Inc), ABCL (AbCellera Biologics Inc), ABEO (Abeona Therapeutics Inc).

What VAQO's model says about ACRS

Two statistical models run over ACRS inside the browser, reporting momentum, risk and opportunity separately. Full accuracy for both, including when it falls, is published on the model page.

ACRS at a glance

Symbol: ACRS
Name: Aclaris Therapeutics Inc
Sector: HEALTHCARE
Industry: BIOTECHNOLOGY
Exchange: NASDAQ
Instrument: Stock

ACRS — frequently asked questions

What is the market cap of ACRS?

Aclaris Therapeutics Inc has a market capitalisation of roughly $544.6M.

What is the 52-week range for ACRS?

ACRS has traded between $1.74 and $6.60 over the past year, with the current price at 44% of that range.

How much does ACRS stock cost today?

Aclaris Therapeutics Inc (ACRS) trades at $3.90, a change of +8.03% in the latest session.

Is ACRS up or down today?

ACRS is up 8.03% in the latest session, at $3.90.

What is the daily trading range for ACRS?

ACRS traded between $3.62 and $3.98 in the latest session, and currently trades at $3.90.

What is the trading volume for ACRS?

ACRS traded roughly 3.5M shares in the latest session.

Which exchange is ACRS listed on?

ACRS is listed on NASDAQ, in the HEALTHCARE sector.

Should I buy ACRS stock?

VAQO gives no buy or sell recommendations and is not an investment adviser. The ACRS figures on this page — price, range, volume and the model's scores — are there to inform your decision, not to stand in for it.

Traded alongside ACRS

← All stocks on VAQO

Last updated: 2026-11-08